betula
Betula pendula, commonly known as silver birch, warty birch, European white birch, or East Asian white birch, is a species of tree in the family Betulaceae, native to Europe and parts of Asia, though in southern Europe, it is only found at higher altitudes. Its range extends into Siberia, China, and southwest Asia in the mountains of northern Turkey, the Caucasus, and northern Iran. It has been introduced into North America, where it is known as the European white birch or weeping birch and is considered invasive in some states in the United States and parts of Canada. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Earliest trial started Feb 12, 2018 (NCT04338477)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSR889N2L976 ↗
- WikipediaBetula pendula ↗
- NCATSJQ5HI5004M ↗
- NCATS93963RFO1P ↗
- NCATS41A3V2257T ↗
- NCATS3R393IX840 ↗
- NCATS3538FNV8AY ↗
- NCATSZL5TV40C5Y ↗
Also known as
- betula
- betula
- betulae cortex dry extract (5-10 : 1); extraction solvent: n-heptane 95% (w/w)
- birch, iron-wood
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05119751 | Phase 4 | Oct 25, 2021 | ALK-Abello, S.A., Clinique Spécialisée en Allergies de la Capitale |
| NCT04338477 | Phase 3 | Feb 12, 2018 | Bioforce AG |
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ALK-Abello, S.A. | For profit | 1 | 0 | 1 | 2021 |
| Bioforce AG | For profit | 1 | 1 | 1 | 2018 |
| Clinique Spécialisée en Allergies de la Capitale | Academic/Hospital | 1 | 1 | 1 | 2021 |